FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula (I) and their pharmaceutically acceptable salts, wherein A is thiazolyl, oxazolyl, thienyl, furyl, imidazolyl, pyrazolyl or oxadiazolyl (structures of which are presented in cl.1 of the patent claim), R1 represents C1-6alkyl; R2 represents (i) phenyl substituted by halogen; C1-6alkyl optionally substituted by morpholine or C1-6dialkylamino; C1-6alkoxy optionally substituted by halogen; or heterocyclyl, wherein a heterocyclyl substitute is specified in morpholine; pyrazolyl optionally substituted by C1-6alkyl; piperidinyl; pyrrolidinyl; oxadiazolyl substituted by C1-6alkyl; furyl substituted by C1-6alkyl; dioxydoisothiazolidinyl; triazolyl; tetrazolyl substituted by C1-6alkyl, tridiazolyl substituted by C1-6alkyl; thiazolyl substituted by C1-6alkyl; pyridyl; or pyrazinyl; (ii) substituted or unsubstituted heterocyclyl specified in quinolinyl; pyridyl substituted by C1-6alkoxy or morpholinyl; or benzo [d] [1, 2, 3] triazolyl substituted by C1-6alkyl; R3 represents phenyl substituted by 2 or 3 substitutes specified in halogen; C1-6alkyl; C1-6alkoxy optionally substituted by halogen; hydroxy group; cyano; or -C(=O)ORa, wherein Ra represents phenyl; R4 represents hydrogen, C1-6alkyl or C1-6halogenalkyl. The invention also refers to a pharmaceutical composition containing the compounds of formula (I), a method for PDE10 inhibition, a method of treating neurological disorders, and to intermediate compounds: 2-(4-chlor-3,5-dimethoxyphenyl)furan and 4-(5-methyl-1,3,4-thiadiazol-2-yl)benzaldehyde.
EFFECT: compounds of formula (I) as PDE10 inhibitors.
39 cl, 13 ex, 2 tbl, 77 dwg
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED METHYLPHENYL KETONES SUITABLE FOR USE AS PDE4 INHIBITORS | 2007 |
|
RU2493149C2 |
NITROCATECHOL DERIVATIVES AS COMP INHIBITORS | 2006 |
|
RU2441001C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
HETEROCYCLIC SUBSTANCES-GPR119 AGONISTS | 2017 |
|
RU2734500C2 |
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
DERIVATIVES OF BENZODIAZEPINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2278865C2 |
COMPOUNDS WITH MEDICINAL EFFECTS DUE TO INTERACTION WITH GLUCOCORTICOID RECEPTOR | 2006 |
|
RU2430086C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
METHODS AND INTERMEDIATE COMPOUNDS FOR PRODUCING A PDE10 INHIBITOR | 2015 |
|
RU2718863C2 |
Authors
Dates
2015-03-27—Published
2011-03-10—Filed